LifeSci Capital LLC
Bob Spivak currently serves as Vice President of Investment Banking at LifeSci Capital LLC, where involvement spans from May 2018 to the present with a focus on healthcare. Previously, Bob held the position of Vice President at LifeSci Acquisition II Corp., overseeing the successful merger with Science 37, Inc. Bob also served as Vice President at LifeSci Acquisition Corp., facilitating the merger with Vincerx Pharma. Earlier experiences include roles at Maxim Group, LifeSci Advisors, New York State Homes and Community Renewal, and Kforce Inc., ranging from analyst to intern positions. Bob Spivak holds a Bachelor of Business Administration in Finance and Applied Mathematics from Pace University, earned between 2015 and 2019.
This person is not in any teams
LifeSci Capital LLC
LifeSci Capital is a research-driven investment bank with deep domain expertise in the life sciences. Our service model as a boutique investment bank is unique in that we exclusively serve corporate clients who are emerging life science companies that discover, develop, and commercialize innovative products. We view our clients as our partners, and we work closely with them to establish and execute their capital markets strategies. Our broadly-distributed equity research product is differentiated and provides a deep understanding of our clients’ businesses and the opportunities they are addressing. LifeSci Capital is a common control affiliate of LifeSci Advisors and has been contracted to provide equity research coverage for the clients of LifeSci Advisors. LifeSci Advisors provides strategic counsel, customized marketing communications and investor relations services to companies in the life sciences, medical technology, and healthcare industries. Member FINRA/SIPC | www.finra.org